Organization
King Saud University
3 clinical trials
2 abstracts
Abstract
Predictors of survival outcome of TAS102 combined with bevacizumab compared to TAS102 alone in Saudi patients with metastatic colorectal cancer beyond second line of systemic therapy.Org: Makkah Saudi Arabia, King Abdulla Medical City/Makkah, Mekkah, Umm AlQura University, King Abdulaziz Medical City (NGHA),
Clinical trial
Effect of Multi-Strain Probiotics as an Anti-Obesity Among Overweight and Obese Saudi AdultsStatus: Completed, Estimated PCD: 2023-08-03
Clinical trial
Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 DiabetesStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
Extraction and Socket Preservation Before Implant Placement Using Freezed Dried Allograft (FDBA) and Platelet-Rich Fibrin in Smokers. A Single Blinded Randomized Controlled Clinical TrialStatus: Completed, Estimated PCD: 2023-03-20
Abstract
A COMPARISON BETWEEN THE ADVERSE EVENTS OF THREE JAK INHIBITORS. A RETROSPECTIVE REAL-WORLD MULTICENTRE REGISTERY STUDYOrg: University Hospital Sharjah, University of Sharjah, King Saud University, Hamad Medical Corporation, Umm Al-Qura University,